These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30148578)

  • 1. [GUIDELINES FOR DIAGNOSIS AND TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROME].
    Šimec NG; Kaić G; Škrtić A; Šiftar Z; Lasan-Trčić R; Valković T; Puškarić BJ; Rogulj IM; Zatezalo V; Nemet D; Kolonić SO
    Lijec Vjesn; 2017; 139(1-2):1-11. PubMed ID: 30148578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
    Garcia-Manero G
    Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics and molecular genetics of myelodysplastic neoplasms.
    Ning Y; Zhang Y; Kallen MA; Emadi A; Baer MR
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101512. PubMed ID: 38092472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
    Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
    BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of childhood myelodysplastic syndrome].
    Hasegawa D
    Rinsho Ketsueki; 2021; 62(4):229-238. PubMed ID: 33967145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].
    Aul C; Giagounidis A; Germing U; Ganser A
    Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management.
    Garcia-Manero G
    Am J Hematol; 2011 Jun; 86(6):490-8. PubMed ID: 21594886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic neoplasms: An overview on diagnosis, risk-stratification, molecular pathogenesis, and treatment.
    Marques FK; Sabino AP
    Biomed Pharmacother; 2022 Dec; 156():113905. PubMed ID: 36306593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management.
    Montalban-Bravo G; Garcia-Manero G
    Am J Hematol; 2018 Jan; 93(1):129-147. PubMed ID: 29214694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
    Babushok DV; Bessler M; Olson TS
    Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. World Health Organization classification of myelodysplastic syndromes.
    Czader M; Orazi A
    Curr Pharm Des; 2012; 18(22):3149-62. PubMed ID: 22571693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis and Therapy of Myelodysplastic Syndrome].
    Bonadies N
    Ther Umsch; 2022; 79(2):93-105. PubMed ID: 35291847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current approach to the diagnosis of myelodysplastic syndromes
    Weinberg OK; Hasserjian RP
    Semin Hematol; 2019 Jan; 56(1):15-21. PubMed ID: 30573039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel combinations to improve hematopoiesis in myelodysplastic syndrome.
    Syed K; Naguib S; Liu ZJ; Cimmino L; Yang FC
    Stem Cell Res Ther; 2020 Mar; 11(1):132. PubMed ID: 32197634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapy.
    Dan C; Chi J; Wang L
    Ann Med; 2015 May; 47(3):209-17. PubMed ID: 25861829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.
    Waszczuk-Gajda A; Mądry K; Machowicz R; Drozd-Sokołowska J; Stella-Hołowiecka B; Mital A; Obara A; Szmigielska-Kapłon A; Sikorska A; Subocz E; Jędrzejczak WW; Dwilewicz-Trojaczek J
    Adv Clin Exp Med; 2016; 25(4):633-41. PubMed ID: 27629836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes.
    Nakajima H
    Intern Med; 2021 Jan; 60(1):15-23. PubMed ID: 32009100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelodysplastic syndrome, acute leukemia and stem cell transplantation].
    Schmalzing M; Aringer M; Bornhäuser M; Atta J
    Z Rheumatol; 2017 Oct; 76(Suppl 2):26-32. PubMed ID: 29330757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.